FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gale Smith

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Procedures

Co-author Network

Publications

TOP 3
Ye V Liu; Michael J Massare; Margret Nathan; Dale L Barnard; Thomas Kort; Lei Wang; Gale Smith
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.
Sang-Moo Kang; Peter Pushko; Rick A Bright; Gale Smith; Richard W Compans
Influenza virus-like particles as pandemic vaccines.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gale Smith (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ye V Liu; Michael J Massare; Margret Nathan; Dale L Barnard; Thomas Kort; Lei Wang; Gale Smith
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
Vaccine 2011;29(38):6606-13.
2009: Lucy A Perrone; Attiya Ahmad; Vic Veguilla; Xiuhua Lu; Gale Smith; Jacqueline M Katz; Peter Pushko; Terrence M Tumpey
Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge.
Journal of virology 2009;83(11):5726-34.
2009: Sang-Moo Kang; Peter Pushko; Rick A Bright; Gale Smith; Richard W Compans
Influenza virus-like particles as pandemic vaccines.
Current topics in microbiology and immunology 2009;333():269-89.
2008: Rick A Bright; Donald M Carter; Corey J Crevar; Franklin Toapanta Yanchapaxi; Jonathan Steckbeck; Kelly S Cole; niranjan kumar; Peter Pushko; Gale Smith; Terrence M Tumpey; Ted M Ross
Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.
PloS one 2008;3(1):e1501.
2007: Bao-Zhong Wang; Weimin Liu; Sang-Moo Kang; Munir Alam; Chunzi Huang; Ling Ye; Yuliang Sun; Yingying Li; Denise L Kothe; Peter Pushko; Terje Dokland; Barton F Haynes; Gale Smith; Beatrice H Hahn; Richard W Compans
Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
Journal of virology 2007;81(20):10869-78.
2007: Peter Pushko; Terrence M Tumpey; Neal Van Hoeven; Jessica A Belser; Robin Robinson; Margret Nathan; Gale Smith; D Craig Wright; Rick A Bright
Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.
Vaccine 2007;25(21):4283-90.
2007: Rick A Bright; Donald M Carter; Shannon Daniluk; Franklin Toapanta Yanchapaxi; Attiya Ahmad; Victor Gavrilov; Mike Massare; Peter Pushko; Nutan Mytle; Thomas Rowe; Gale Smith; Ted M Ross
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Vaccine 2007;25(19):3871-8.
2005: Peter Pushko; Terrence M Tumpey; Fang Bu; John Knell; Robin Robinson; Gale Smith
Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
Vaccine 2005;23(50):5751-9.